Abstract:ResumoObjetivo: Determinar a repercussão do uso de antibióticos pelas mães no resultado das hemoculturas e culturas de secreções dos recém-nascidos com suspeita clínica de infecção precoce.Material e Métodos: No período de agosto de 1995 a julho de 1996, foram analisados 69 casos seqüenciais de recém-nascidos com sepse ou síndrome séptica precoce. Os recém-nascidos foram acompanhados para seus desfechos clínicos: crescimento ou não de germe em suas culturas de secreções (sangue, urina, líquor, secreção traquea… Show more
“…This is much too high to base the decision not to start empirical antibiotics for a neonate with suspected sepsis. Particularly as CRP was only tested to predict positive blood culture which may represent only a proportion of neonates with sepsis [ 24 ], especially if the patient had been on antibiotic therapy before presentation as is common in Sub-Saharan Africa. A negative CRP, however can be useful in aiding the decision to discontinue antibiotics especially if the neonate has no clinical feature of sepsis.…”
BackgroundSepsis is one of the most common causes of morbidity and mortality in the newborn. Early diagnosis and treatment is vital to improve outcome. The present study was therefore carried out to determine the usefulness of C-reactive protein (CRP) for evaluation of neonatal sepsis in Port Harcourt, Nigeria in Sub-Saharan Africa.MethodFour hundred and twenty neonates with clinical suspicion of sepsis were prospectively studied over a 6 month period. Blood was obtained from each subject recruited for the qualitative estimation of CRP. Blood culture was used as gold standard for diagnosis of NNS.ResultsOf 420 neonates studied, 196 (46.7%) had positive CRP while 181 (43.1%) had positive blood culture. The sensitivity, specificity, positive and negative predictive values of CRP were 74.0%, 74.1%, 68.4% and 79.0% respectively.ConclusionThe qualitative method of estimating CRP which is cheap and rapid has moderate sensitivity, specificity and negative predictive value.
“…This is much too high to base the decision not to start empirical antibiotics for a neonate with suspected sepsis. Particularly as CRP was only tested to predict positive blood culture which may represent only a proportion of neonates with sepsis [ 24 ], especially if the patient had been on antibiotic therapy before presentation as is common in Sub-Saharan Africa. A negative CRP, however can be useful in aiding the decision to discontinue antibiotics especially if the neonate has no clinical feature of sepsis.…”
BackgroundSepsis is one of the most common causes of morbidity and mortality in the newborn. Early diagnosis and treatment is vital to improve outcome. The present study was therefore carried out to determine the usefulness of C-reactive protein (CRP) for evaluation of neonatal sepsis in Port Harcourt, Nigeria in Sub-Saharan Africa.MethodFour hundred and twenty neonates with clinical suspicion of sepsis were prospectively studied over a 6 month period. Blood was obtained from each subject recruited for the qualitative estimation of CRP. Blood culture was used as gold standard for diagnosis of NNS.ResultsOf 420 neonates studied, 196 (46.7%) had positive CRP while 181 (43.1%) had positive blood culture. The sensitivity, specificity, positive and negative predictive values of CRP were 74.0%, 74.1%, 68.4% and 79.0% respectively.ConclusionThe qualitative method of estimating CRP which is cheap and rapid has moderate sensitivity, specificity and negative predictive value.
“…This value is higher for making a decision not to start empirical antibiotic therapy for a suspected septic neonate, particularly when CRP is estimated keeping blood culture gold standard, and its positivity may represent only a proportion these subjects. 19 Particularly, if a neonate is given antibiotics before presenting to the clinician as is common in our setup or if mother is given antibiotics intra-partum. A negative CRP test in neonates without clinical feature is helpful in making decision to discontinue antibiotics, thus facilitating early discharge with significant reduction in complications and cost of treatment.…”
Objectives: To determine the diagnostic accuracy of C-reactive protein in the diagnosis of neonatal sepsis keeping blood cultures as gold standard. Study Design: Descriptive cross-sectional study. Setting: Pediatric Unit of Lady Reading Hospital Peshawar Pakistan. Duration: Six months from 09-06-2012 to 08-12-2012. Methodology: Total of 196 patients meeting the required inclusion criteria with clinical suspicion of sepsis. Those neonates were subjected to investigations. C.R.P. was tested using the Quantitative method according to the instructions provided with the kit. By keeping blood culture as gold standard, patients with both positive and negative cultures were taken and the results compared to the results of C.R.P. in these subjects being positive or negative. Results: Among the 196, majority of the neonates included were less than a week old having a mean age of 4.5 days. There were 57 (29%) females and 139 (71%) males, with male to female ratio of 2.4:1. Blood cultures were positive in 85 (43%) and negative in 111 (57%) cases, while C.R.P. was positive in 95 (48%) and negative in 101 (52%) cases. Sensitivity, specificity, and positive and predictive values of C-reactive protein were calculated using formulas, and they turned out to be 77.6%, 73.8%, 69.4%, and 81.2% respectively with accuracy being 0.41%. Conclusion: An accurate and timely diagnosis of early onset neonatal sepsis remains challenging to the clinician as well as laboratory. Physicians can prevent unnecessary antibiotic use by performing the qualitative estimation CRP as a single, rapid and inexpensive test with a negative predictive value of 81.2%.
“…Keadaan ini berhubungan dengan pemberian profilaksis antibiotik pada ibu untuk mencegah kolonisasi kuman, tetapi tidak cukup kuat mencegah timbulnya INAD. 26 Hasil biakan dapat positif palsu karena terdapat kontaminasi. 27 Pendapat lain menyatakan bahwa infeksi adalah suatu sindrom klinis akibat proses bakteremi yang melibatkan berbagai organ dan bukan diagnosis akhir, oleh sebab itu sulit menentukan baku emas diagnosis infeksi atau sepsis.…”
Latar belakang. Infeksi awitan dini neonatal masih menjadi masalah karena tingginya angka kesakitan,kematian, biaya perawatan, dan akan menimbulkan komplikasi tumbuh kembang di kemudian harikhususnya bayi prematur. Di sisi lain diagnosis cepat sangat diperlukan terutama untuk menentukan saatpemberian antibiotik.Tujuan. Mengetahui hubungan faktor risiko maternal sebagai prediktor terjadinya infeksi neonatal awitandini (INAD).Metode. Studi kasus kontrol, retrospektif terhadap pasien neonatus yang dirawat di Unit Perawatan IntensifNeonatal, Rumah Sakit Anak dan Bunda ”Harapan Kita” sejak Desember 2008 sampai dengan November2010. Data dianalisis secara multivariat regresi logistik dengan menggunakan program SPSS 16.0.Hasil. Subyek penelitian 566 bayi baru lahir dari 5094 kelahiran selama periode dua tahun; ditemukan179 neonatus (35,17 per 1000 kelahiran) didiagnosis tersangka INAD, 12 (6,7%) terbukti berdasarkanpemeriksaan biakan darah. Jenis kuman adalah Staphylococcus epidermidis (6), candida sp (2), Staphylococcusaureus (1), Streptococcus B hemoliticus (1), Streptococcus maltophilia (1), serratia sp (1). Faktor risikoleukositosis (15.000 sel/mm3) pada ibu dan adanya leukosit (5/LPB) dalam cairan lambung bayi yangdiaspirasi segera setelah lahir memiliki probabilitas sebagai prediktor kemungkinan neonatus menderitainfeksi awitan dini sebesar 67.7%.Kesimpulan. Peningkatan jumlah leukosit darah ibu dan peningkatan jumlah leukosit dalam cairan lambungbayi yang diaspirasi segera setelah lahir merupakan prediktor kemungkinan neonatus menderita infeksiawitan dini
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.